No Data
Tibet Aim Pharm. Inc. (002826.SZ): In the first quarter, the net income was 18.7939 million yuan, a year-on-year decrease of 32.64%.
On April 25, Gelonghui reported that Tibet Aim Pharm. Inc. (002826.SZ) announced its Q1 2025 report, achieving revenue of 0.149 billion yuan, a year-on-year decrease of 7.41%; net income attributable to shareholders of the listed company was 18.7939 million yuan, a year-on-year decrease of 32.64%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 10.2354 million yuan, a year-on-year increase of 475.03%; EPS was 0.10 yuan.
Yiming Pharmaceutical: 2024 Annual Report Summary
Yiming Pharmaceutical: Report for the first quarter of 2025
Yiming Pharmaceutical: 2024 Annual Report
Tibet Aim Pharm. Inc. (002826.SZ): Received a government subsidy of 10 million yuan.
Gelonghui reported on March 31 that Tibet Aim Pharm. Inc. (002826.SZ) announced that the company recently received a special industry support fund of 10 million yuan allocated by the Management Committee of the Lhasa Economic and Technological Development Zone for the year 2024, accounting for 64.99% of the audited Net income attributable to Shareholders of the listed company for the year 2023.
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
